BiomeSense

• ·BiomeSense’s last known valuation is $19.2M (Dec 2023).
• ·It has raised $16.2M across 3 recorded rounds; the latest was Early Stage VC ($7.1M) in Jul 2025.
• ·Notable investors include US National Science Foundation, SOSV, Service Provider Capital, IndieBio, Labcorp Venture Fund — 23 tracked in total.
• ·1 investment vehicle was formed to buy BiomeSense shares in the last 12 months, reporting $220K sold to 21 investors, per SEC Form D filings.
• ·BiomeSense has filed 2 Form Ds with the SEC since 2019, most recently Dec 2023 ($6.2M sold to 33 investors).
• ·Status: Privately Held (backing).

In the last 12 months, 1 investment vehicle were formed to buy BiomeSense shares, reporting $220K sold to 21 investors. Most recent filing Oct 2025. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

Developer of an integrated precision measurement and analytics platform designed to transform microbiome data generation and analysis. The company's platform produces and analyzes large-scale, densely longitudinal microbiome datasets to discover, validate, and commercialize novel microbiome biomarkers at scale, enabling doctors to gain insights into understanding and leveraging the microbiome for human health.

Sector

Healthcare

HQ

Chicago, IL, United States

Founded

2018

Employees

9

Website

biomesense.com/

Ownership

Privately Held (backing)